Skip to content

QUantiferon in Active and Latent Infection with Tuberculous mYcobacteria

QUantiferon in Active and Latent Infection with Tuberculous mYcobacteria - QUALITY-study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42494
Enrollment
325
Registered
2015-08-11
Start date
2015-11-24
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TB Tuberculosis

Interventions

None listed

Sponsors

Diakonessenhuis Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Latent or active tuberculosis in history or at this moment

Exclusion criteria

Exclusion criteria: Age

Design outcomes

Primary

MeasureTime frame
The differences in QFT-Plus assay results (positive or negative) and the level of response between the different tubes and different groups The differences in QFT-Plus assay response during treatment in subjects with active tuberculosis

Secondary

MeasureTime frame
Other cytokines than interferon gamma enabling to distinguish active TB disease from latent TB infection Cell characteristics enabling to distinguish active TB disease from latent TB infection

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)